Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
Open Access
- 31 March 2003
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 39 (4) , 488-494
- https://doi.org/10.1016/s0959-8049(02)00747-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli InstituteAnnals of Oncology, 2001
- Chemotherapy in osteosarcomaActa Orthopaedica, 1999
- Long-term results of the co-operative German–Austrian–Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbsPublished by Elsevier ,1998
- High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.Journal of Clinical Oncology, 1997
- Expression of P-Glycoprotein in High-Grade Osteosarcomas in Relation to Clinical OutcomeNew England Journal of Medicine, 1995
- Serum Methotrexate (MTX) Concentrations and Prognosis in Patients with Osteosarcoma of the Extremities Treated with a Multidrug Neoadjuvant RegimenJournal of Chemotherapy, 1993
- The Importance of Dose-Intensity in Neoadjuvant Chemotherapy of Osteosarcoma: A retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperativelyJournal of Chemotherapy, 1990
- Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescentsZeitschrift für Krebsforschung und Klinische Onkologie, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- A System for the Surgical Staging of Musculoskeletal SarcomaClinical Orthopaedics and Related Research, 1980